

Definitive Healthcare reports Q1 adjusted EPS of $0.08, sales at $63.48M, and adjusted EBITDA of $20 million. Q2 revenue guidance: $62–$63.5 million. FY 2024...
You can purchase shares of Definitive Healthcare (NASDAQ:DH) through any online brokerage.
Other companies in Definitive Healthcare’s space includes: Veeva Systems Inc (NYSE:VEEV), Doximity Inc (NYSE:DOCS), Waystar Holding Corp (NASDAQ:WAY), HeartFlow Inc (NASDAQ:HTFL) and Schrodinger Inc (NASDAQ:SDGR).
Definitive Healthcare has a consensus price target of $4.13.
The stock price for Definitive Healthcare (NASDAQ: DH) is $1.08 last updated October 22, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Definitive Healthcare.
Definitive Healthcare does not have any upcoming earnings scheduled.
There is no upcoming split for Definitive Healthcare.
Definitive Healthcare is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The...